Edition:
United Kingdom

Aphria Inc (APH.TO)

APH.TO on Toronto Stock Exchange

11.75CAD
13 Jul 2018
Change (% chg)

$-0.23 (-1.92%)
Prev Close
$11.98
Open
$11.96
Day's High
$12.04
Day's Low
$11.70
Volume
1,736,654
Avg. Vol
4,306,132
52-wk High
$24.75
52-wk Low
$5.62

Select another date:

Thu, May 17 2018

BRIEF-Aphria's German Subsidiary Acquires Interest In Berlin-Based Shöneberg Hospital

* APHRIA'S GERMAN SUBSIDIARY, NUUVERA DEUTSCHLAND, ACQUIRES INTEREST IN BERLIN-BASED SHÖNEBERG HOSPITAL

BRIEF-Aphria Amends Arrangement Agreement With Nuuvera

* APHRIA - CO, NUUVERA AGREED TO AMEND DEAL TO REDUCE REQUIRED LEVEL OF UNRESTRICTED CASH & CONSIDERATION PAYABLE TO NUUVERA'S SHARESHOLDERS

BRIEF-Aphria Signs LoI With SAQ To Supply Up To 12,000 KG Of Cannabis Annually

* APHRIA SIGNS LETTER OF INTENT WITH SAQ TO SUPPLY UP TO 12,000 KG OF CANNABIS ANNUALLY TO QUEBEC MARKET Source text for Eikon: Further company coverage:

BRIEF-Aphria Says Divested About 26.7 Mln Shares In Liberty, At $1.25 Per Share

* APHRIA BEGINS TO DIVEST OF ITS EQUITY INVESTMENT IN PASSIVE US ASSETS

Pot company Aphria to sell stake in U.S. cannabis grower

Canadian marijuana company Aphria Inc said on Friday it agreed to sell its minority stake in U.S.-based Copperstate Farms to Liberty Health Sciences Inc for C$20 million ($16.14 million).

BRIEF-Aphria And Liberty Health Announce Sale Of Aphria's Investment In Copperstate Farms To Liberty

* APHRIA AND LIBERTY HEALTH SCIENCES ANNOUNCE DEFINITIVE AGREEMENT FOR SALE OF APHRIA'S INVESTMENT IN COPPERSTATE FARMS TO LIBERTY

BRIEF-Aphria Considers Strategic Alternatives For Its U.S. Cannabis Interests

* APHRIA CONSIDERS STRATEGIC ALTERNATIVES FOR ITS US CANNABIS INTERESTS

Canada cannabis firm Aphria mulls sale of U.S. unit

Feb 1 Canadian cannabis company Aphria Inc said on Thursday it was exploring strategic alternatives, including a sale, for its U.S. business, amid tightening enforcement of federal cannabis laws in the country. Earlier this year, the U.S. Department of Justice revoked an Obama administration policy that discouraged federal prosecutors from pursuing marijuana-related crimes in states that had legalized the drug.

Canada's Aphria to buy rival Nuuvera for $670 million

Canadian cannabis company Aphria Inc said Monday it would buy rival Nuuvera Inc for C$826 million ($670 million), ahead of a raft of medical cannabis approvals around the world over the coming years.

UPDATE 2-Canada's Aphria to buy rival Nuuvera for $670 million

Jan 29 Canadian cannabis company Aphria Inc said Monday it would buy rival Nuuvera Inc for C$826 million ($670 million), ahead of a raft of medical cannabis approvals around the world over the coming years.

Select another date: